Understanding the dose-response relationship of allopurinol: predicting the optimal dosage

Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol

(2012) Lisa K. Stamp et al.   ARTHRITIS AND RHEUMATISM

The pharmacokinetics of oxypurinol in people with gout

(2012) Sophie L. Stocker et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Furosemide increases plasma oxypurinol without lowering serum urate--a complex drug interaction: implications for clinical practice

(2012) L. K. Stamp et al.   RHEUMATOLOGY

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?

(2011) M. H. Lee et al.   INTERNAL MEDICINE JOURNAL

Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout

(2011) SOPHIE L. STOCKER et al.   JOURNAL OF RHEUMATOLOGY

Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment

(2010) Lisa K. Stamp et al.   ARTHRITIS AND RHEUMATISM

Adherence with urate-lowering therapies for the treatment of gout

(2009) Leslie R Harrold et al.   ARTHRITIS RESEARCH & THERAPY

Higher Therapeutic Plasma Oxypurinol Concentrations Might Be Required for Gouty Patients With Chronic Kidney Disease

(2008) Duangchit Panomvana et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY